Skip to content
Screener

Medtronic MDT Total Revenue

Total Revenue at other companies

Abbott logo
AbbottABT
$12.59B+13.0%
TFX
TeleflexTFX
$570.33M+28.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Stryker logo
StrykerSYK
$6.59B+9.4%
CONMED logo
CONMEDCNMD
$343.49M+0.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%

Segments

By segment

See full
Cardiovascular$3.8B+13.8%
Neuroscience$2.75B+5.0%
Medical Surgical$2.39B+8.0%
Diabetes$838M+15.1%
Other Operating Segments$135M
Other operating segment$32M0.0%

By geography

See full
United States$4.24B
Ireland$28M

Other financials

Income statement

See full
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$117.78B-0.2%
Enterprise value$145.04B-0.3%
P/E24.5×-0.8×
P/S3.2×-0.2×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions, except per share data)Fiscal Year / 2026Fiscal Year / 2025Fiscal Year / 2024
Net sales$36,364$33,537$32,364
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets12,72111,63211,216
Research and development expense2,8732,7322,735
Selling, general, and administrative expense11,78410,84910,736
Amortization of intangible assets1,7721,8071,693
Restructuring charges, net249267226
Certain litigation charges, net113317149

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's total revenue?
Medtronic (MDT) reported total revenue of $9.81B in Q1 2026.
How has Medtronic's total revenue changed year-over-year?
Medtronic's total revenue increased by 9.9% year-over-year, from $8.93B to $9.81B.
What is the long-term trend for Medtronic's total revenue?
Over 4 years (2022 to 2026), Medtronic's total revenue has grown at a 3.5% compound annual growth rate (CAGR), from $31.69B to $36.36B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Medtronic's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude